Whether working with a traditional or a decentralized clinical research model, everyone knows that choosing clinical research sites can make or break the success of patient recruitment and retention on a trial. Some sites will complete on time and budget with happy and supported patients who will continue to the end of the trial, giving clean, high-quality data. While others could face delays, overspends, high dropout rates, incomplete data sets and more.
But what if all sites could be successful?
In this webinar, the featured speaker will highlight the value of having a dedicated site relationship team, along with expert project management and clinical support to assist internal and site teams to:
- Enable increased patient recruitment:
- – On site or remote support to find, engage with and recruit patients.
- Deliver visits:
- – On site support with study visits such as pre-screening, screening, bloods, ECGs, any assessments as per the protocol
- Coordinate a study:
- – Support the site with tasks from informed consent, setting up clinic lists, reviewing all patient referrals, recruitment management all the way through to budget management
- Complete data entry:
- – On site support for any outstanding source date on the eCRF
Join this webinar to hear a site relationship management expert share their knowledge and expertise on optimizing and supporting clinical research sites.
Kerry Leyden, Director of Site Relationship Management, MRN
Prior to joining MRN, Kerry has worked in pharma and CRO for 15 years, primarily focused on patient engagement, recruitment and retention. She has developed targeted study-specific patient recruitment and retention strategies for large portfolios, and overseen execution in collaboration with study teams, by engaging with sites, identifying, qualifying and managing specialized vendors and fostering relationships with both localized and global advocacy organizations. Kerry is passionate about patient centricity and site relationships, striving to ensure the experience for site and patient are equally positive.
Caroline Potts, MSc Health Sciences, MSc Healthcare and Design, Vice President – Visit Delivery, MRN
Caroline has worked for the MRN since 2018, her current role being Vice President – Visit Delivery. Prior to this role, Caroline was Executive Director for Visit Management managing a global team of Project Support Associates and prior to that, a Project Director overseeing a large portfolio of clinical trials as well as managing her own portfolio of trials in haemophilia and Parkinson’s disease.
Before joining MRN, Caroline worked in the public sector for 15 years supporting research in hospitals and the primary care setting as well as providing support to research academics by writing funding applications, making submissions to regulatory authorities and running a large portfolio of studies to ICH-GCP requirements in clinical specialties such as stroke medicine, Parkinson’s disease, orthopaedics, gastrointestinal medicine and respiratory medicine. During this time, Caroline was one of the founding members of the UKRD group as well as an Executive member of the RD Forum providing R&D Directors and research staff working in the public sector with strategic guidance in supporting high quality research in the NHS.
Who Should Attend?
- VP level
- Medical Director
- Clinical Development Director
- Operational Director
- Clinical Director
- Clinical Innovation
- Patient Engagement
- Patient Advocacy
- Patient Recruitment
- Patient Services
- Principal Investigator
- Clinical Trial Managers
- Study Coordinators
- Clinical Trial Manager
- Clinical Research Coordinator
- Director Clinical Research
What You Will Learn
Attendees will learn:
- What are the key challenges sites face when participating in clinical research?
- What should Sponsors consider when looking at potential sites for a trial?
- How to best support trial-naïve research sites?
- How can introducing dedicated trial resources improve the site experience?
MRN has led the way efficiently delivering high quality complex Decentralized Clinical Trials (DCT) from patients’ homes for over 16 years. We understand the complexities of today’s clinical trial environment and the burden placed on both patients and sites. Our decentralized trial and site support solutions are designed to ease these burdens, therefore accelerating patient recruitment, enrollment, and retention, maximizing the impact of the trial for the pharmaceutical sponsor — getting drugs to market faster. MRN are the catalysts of decentralized trials; combining the right clinical and digital DCT elements, to engineer the right solution for each trial. Learn more about MRN: https://themrn.io/
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.Create Account